Pharmacology, Toxicology and Pharmaceutical Science
Autoimmune Hepatitis
100%
Hepatitis A
100%
Coronavirinae
100%
SARS Coronavirus
100%
Diseases
100%
Infection
71%
Immunosuppressive Agent
42%
Disease Course
28%
Remission
14%
Syndrome
14%
Antimalarial Agent
14%
Virus Infection
14%
Liver Enzyme
14%
Immunocompromised Patient
14%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
100%
Autoimmune Hepatitis
100%
Hepatitis A
100%
Immunosuppressive Treatment
71%
Infection
57%
Drug Megadose
28%
Disease Course
28%
Virus Infection
14%
Immunosuppressive Drug
14%
Infection in Immunocompromised Patients
14%
Liver Enzyme
14%
Antimalarial Agent
14%
Nose Smear
14%
Keyphrases
COVID-19
100%
Immunocompromised Patients
100%
Autoimmune Hepatitis
100%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
44%
Immunosuppression
33%
Italy
22%
Immunosuppressive Therapy
22%
Immunosuppressed
22%
High-dose Steroids
22%
Viral Infection
11%
Disease Course
11%
Clinical Outcomes
11%
Clinical Course
11%
Antimalarial Drugs
11%
Hospitalized Patients
11%
Acute Onset
11%
Antiviral Drugs
11%
Liver Enzymes
11%
Infections In Immunocompromised Hosts
11%
Immunosuppressive Medication
11%
Biochemical Relapse
11%
Nasal Swab
11%
Induction Protocol
11%
Respiratory Distress Syndrome
11%
Medical Decision
11%
Immunosuppressed Population
11%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Autoimmune Hepatitis
100%
COVID-19
100%
Hepatitis A
100%
Immunosuppression
42%
Drug Megadose
28%
Immunosuppressive Therapy
28%
Viral Disease
14%
Immunosuppressive Drug
14%
Antimalarial Agent
14%
Immunocompromised Patient
14%